Global Anti-Infective Drugs Market – Industry Trends and Forecast to 2030

Anti-Infective Drugs Market Analysis and Size

Anti-infective drugs have been a primary segment for several pharmaceutical companies for decades. Since the last two decades, the infection rate has increased considerably, mainly across the low and middle-income countries. Several advances in the formulation such as fixed-dose combination and increasing demand of diseases specific treatment are some of the major factors for the demand of antiviral drugs. The anti-infective drugs market is anticipated to grow hugely due to the increasing incidence of targeted diseases and awareness initiatives on anti-infective drugs.

Data Bridge Market Research analyses a growth rate in the anti-infective drugs market in the forecast period 2023-2030. The expected CAGR of anti-infective drugs market is tend to be around 4% in the mentioned forecast period. The market was valued at USD 135 billion in 2022, and it would grow upto USD 184.7 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Anti-Infective Drugs Market Scope and Segmentation

Market Definition

Anti-infective drugs belongs to a class of therapeutics which causes suppression of muscle spasms. These type of drugs help in the stimulation of smooth muscle relaxation especially in the gastrointestinal tract. Antispasmodic medications generally treat symptoms such as stomach pain and cramping. They are most commonly used for the treatment of irritable bowel syndrome symptoms.  

Global Anti-Infective Drugs Market Dynamics

Drivers

• Increasing Awareness About Infectious Diseases

There has been major growth in the number of multidrug-resistant organisms across numerous parts of the world, that further surges the importance of innovation in the anti-infective agents. Numerous institutes have established specific initiatives or campaigns to increase the awareness about infectious diseases among the public. For instance, the World Health Organization performed the World Antimicrobial Awareness Week (WAAW) with the theme, ‘Spread Awareness, Stop Resistance’ in November 2021 to raise awareness about antimicrobial resistance. Thus, this awareness initiatives boost the market growth.

• Growing Demand for Oral Drugs

Oral drugs is estimated to increase the market growth. The segment is expected to rise the global market as many of the products are available in capsule form and tablet form and it is a very common and convenient route of administration.

Opportunities

• Launch of Anti-infective Drugs

Major market players are releasing many products that are helping in boosting the growth of the market.  For instance, in February 2021, Pfizer announced the launch of the C. difficile Awareness Initiative. C. difficile is an infectious bacterium that can cause a serious and potentially life-threatening infection related with symptoms from diarrhea to severe intestinal inflammation. The article specified that an estimate of about 462,000 C. difficile infection cases were being registered in the U.S. each year. The growing number of initiatives by several organizations and major market players on spreading awareness regarding infectious diseases are projected to boost the market growth. Furthermore, Xellia Pharmaceuticals, which is a pharmaceutical manufacturer specializing in anti-infective treatments, in August 2021, opened its manufacturing site in Cleveland, Ohio in U.S. The company released the first anti-infectives which is manufactured at the site for distribution to U.S. hospitals. Such activities are projected to increase the market growth during the forecast period.

Restraints/Challenges

• Lack of skilled professionals

The huge lack of qualified personnel who are not aware of the drugs options to give patients to could hamper the growth of the global anti-infective drugs market during the forecast period 2023-2030.

• Side-effects of anti-infective drugs

Several side effects such as weakness, dizziness, blurred vision, rashes, nausea, dry mouth, and abdominal bloating hamper the market growth. Any of the drug use is restricted because of the government developed guidelines to monitor how and where the medications are utilized.

This anti-infective drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anti-infective drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Anti-Infective Drugs Market Scope

The anti-infective drugs market is segmented on the basis of product type, indication,  route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Antibiotics
• Antivirals
• Antifungals
• Others

Indication

• HIV Infections
• Pneumonia
• Hepatitis
• Herpes Simplex Virus
• Influenza
• Others

Route of Administration

• Oral
• Topical
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Anti-Infective Drugs Market Regional Analysis/Insights

The anti-infective drugs market is analyzed and market size insights and trends are provided by product type, indication,  route of administration, distribution channel and end-user as referenced above.

The major countries covered in the anti-infective drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for anti-infective drugs market throughout the forecasted period because of the sophisticated healthcare infrastructure, increasing awareness in society, well-established distribution channels, and a huge presence of e-commerce across the U.S. and Canada.

Asia-Pacific dominates the market because of the increasing attention of major market players to establish numerous emerging economics with significant growth. With the opening of several new hospitals and pharmacies in this area, the market is expanding.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Anti-Infective Drugs Market Share Analysis

The anti-infective drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anti-infective drugs market

Key players operating in the anti-infective drugs market include:

• Takeda Pharmaceutical Company Limited (Japan)
• Johnsons & Johnsons Services Inc (U.S.)
• Boehringer Ingelheim International GmbH (Germany)
• Abbvie, Inc (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Sanofi (France)
• GSK Plc. (U.K.)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Alvogen (U.S)
• Hikma Pharmaceuticals PLC (U.K.)
• Alembic Pharmaceuticals Limited (India)
• Zydus Group (India)

SKU-52944